Traws Pharma Stock Price History
| TRAW Stock | 4.58 0.16 3.38% |
Below is the normalized historical share price chart for Traws Pharma extending back to July 25, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Traws Pharma stands at 4.58, as last reported on the 1st of December, with the highest price reaching 4.58 and the lowest price hitting 4.51 during the day.
If you're considering investing in Traws Stock, it is important to understand the factors that can impact its price. Traws Pharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.2, which indicates the firm had a -0.2% return per unit of risk over the last 3 months. Traws Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Traws Pharma's Risk Adjusted Performance of (0.13), variance of 22.23, and Coefficient Of Variation of (544.48) to confirm the risk estimate we provide.
At this time, Traws Pharma's Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to climb to about 511.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 15.7 M in 2024. . At this time, Traws Pharma's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to climb to 20.90 in 2024, whereas Price Earnings Ratio is likely to drop (22.97) in 2024. Traws Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of January 2001 | 200 Day MA 0.6214 | 50 Day MA 0.3792 | Beta 1.394 |
Traws |
Sharpe Ratio = -0.2037
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TRAW |
Estimated Market Risk
| 4.74 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.96 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Traws Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Traws Pharma by adding Traws Pharma to a well-diversified portfolio.
Price Book 1.6745 | Enterprise Value Ebitda 0.3293 | Price Sales 39.1656 | Shares Float 22.4 M | Wall Street Target Price 6.5 |
Traws Pharma Stock Price History Chart
There are several ways to analyze Traws Stock price data. The simplest method is using a basic Traws candlestick price chart, which shows Traws Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 6, 2024 | 9.05 |
| Lowest Price | November 26, 2024 | 4.09 |
Traws Pharma December 1, 2024 Stock Price Synopsis
Various analyses of Traws Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Traws Stock. It can be used to describe the percentage change in the price of Traws Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Traws Stock.| Traws Pharma Price Daily Balance Of Power | (2.29) | |
| Traws Pharma Price Rate Of Daily Change | 0.97 | |
| Traws Pharma Price Action Indicator | (0.04) |
Traws Pharma December 1, 2024 Stock Price Analysis
Traws Stock Price History Data
The price series of Traws Pharma for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 5.17 with a coefficient of variation of 26.81. The price distribution for the period has arithmetic mean of 6.06. The median price for the last 90 days is 5.24. The company completed stock split (1:15) on 21st of May 2021.| Open | High | Low | Close | Volume | ||
12/01/2024 | 4.58 | 4.58 | 4.51 | 4.58 | ||
| 11/29/2024 | 4.58 | 4.58 | 4.51 | 4.58 | 3,915 | |
| 11/27/2024 | 4.10 | 4.75 | 4.10 | 4.74 | 8,590 | |
| 11/26/2024 | 4.40 | 4.47 | 4.06 | 4.09 | 19,126 | |
| 11/25/2024 | 4.51 | 4.66 | 4.34 | 4.46 | 4,805 | |
| 11/22/2024 | 4.60 | 4.64 | 4.36 | 4.46 | 5,986 | |
| 11/21/2024 | 4.32 | 4.85 | 4.32 | 4.51 | 3,863 | |
| 11/20/2024 | 4.70 | 4.70 | 4.16 | 4.49 | 9,897 | |
| 11/19/2024 | 4.83 | 4.92 | 4.70 | 4.70 | 6,937 | |
| 11/18/2024 | 4.96 | 5.13 | 4.82 | 4.93 | 4,505 | |
| 11/15/2024 | 5.31 | 5.31 | 4.85 | 4.99 | 5,966 | |
| 11/14/2024 | 5.60 | 5.60 | 5.50 | 5.58 | 4,655 | |
| 11/13/2024 | 5.81 | 5.85 | 5.57 | 5.65 | 4,300 | |
| 11/12/2024 | 5.30 | 5.96 | 5.30 | 5.90 | 11,284 | |
| 11/11/2024 | 5.32 | 5.49 | 5.28 | 5.41 | 13,925 | |
| 11/08/2024 | 5.02 | 5.45 | 4.95 | 5.32 | 6,777 | |
| 11/07/2024 | 4.88 | 5.25 | 4.88 | 5.06 | 9,725 | |
| 11/06/2024 | 4.98 | 5.05 | 4.88 | 5.05 | 15,143 | |
| 11/05/2024 | 5.05 | 5.30 | 4.98 | 4.99 | 13,778 | |
| 11/04/2024 | 5.18 | 5.18 | 4.95 | 5.00 | 2,484 | |
| 11/01/2024 | 4.98 | 5.17 | 4.92 | 4.99 | 2,606 | |
| 10/31/2024 | 5.13 | 5.13 | 4.97 | 5.04 | 1,352 | |
| 10/30/2024 | 4.99 | 5.15 | 4.97 | 4.97 | 3,341 | |
| 10/29/2024 | 5.06 | 5.23 | 5.00 | 5.05 | 6,524 | |
| 10/28/2024 | 4.90 | 5.12 | 4.86 | 4.94 | 4,909 | |
| 10/25/2024 | 5.15 | 5.15 | 4.72 | 4.96 | 9,609 | |
| 10/24/2024 | 4.85 | 5.35 | 4.63 | 5.06 | 30,917 | |
| 10/23/2024 | 4.91 | 4.91 | 4.74 | 4.86 | 10,219 | |
| 10/22/2024 | 4.69 | 5.00 | 4.50 | 4.85 | 33,330 | |
| 10/21/2024 | 4.82 | 5.00 | 4.59 | 4.65 | 7,474 | |
| 10/18/2024 | 4.68 | 4.93 | 4.68 | 4.87 | 3,232 | |
| 10/17/2024 | 4.70 | 4.95 | 4.70 | 4.70 | 4,932 | |
| 10/16/2024 | 4.96 | 4.96 | 4.57 | 4.74 | 14,184 | |
| 10/15/2024 | 5.00 | 5.26 | 4.77 | 4.80 | 6,925 | |
| 10/14/2024 | 5.19 | 5.40 | 5.00 | 5.01 | 16,453 | |
| 10/11/2024 | 4.89 | 5.30 | 4.89 | 5.22 | 4,008 | |
| 10/10/2024 | 4.67 | 4.89 | 4.67 | 4.89 | 3,348 | |
| 10/09/2024 | 4.80 | 4.80 | 4.44 | 4.69 | 9,816 | |
| 10/08/2024 | 5.04 | 5.12 | 4.78 | 4.80 | 13,388 | |
| 10/07/2024 | 5.98 | 5.98 | 4.62 | 5.24 | 35,463 | |
| 10/04/2024 | 5.47 | 5.84 | 5.47 | 5.53 | 5,642 | |
| 10/03/2024 | 5.65 | 5.72 | 5.35 | 5.55 | 7,784 | |
| 10/02/2024 | 5.60 | 5.70 | 5.13 | 5.70 | 9,411 | |
| 10/01/2024 | 5.80 | 5.80 | 5.32 | 5.58 | 13,681 | |
| 09/30/2024 | 6.02 | 6.39 | 5.69 | 5.88 | 28,156 | |
| 09/27/2024 | 5.88 | 6.60 | 5.64 | 5.74 | 39,273 | |
| 09/26/2024 | 7.05 | 7.05 | 6.00 | 6.10 | 24,038 | |
| 09/25/2024 | 7.22 | 7.50 | 6.86 | 7.03 | 29,466 | |
| 09/24/2024 | 7.00 | 7.50 | 6.96 | 7.44 | 21,009 | |
| 09/23/2024 | 6.99 | 7.72 | 6.43 | 7.50 | 50,269 | |
| 09/20/2024 | 7.50 | 8.17 | 6.76 | 7.11 | 30,434 | |
| 09/19/2024 | 7.99 | 8.00 | 7.45 | 7.75 | 20,524 | |
| 09/18/2024 | 8.75 | 9.17 | 6.01 | 7.70 | 35,315 | |
| 09/17/2024 | 8.50 | 8.75 | 8.42 | 8.57 | 3,592 | |
| 09/16/2024 | 8.74 | 8.99 | 8.01 | 8.50 | 2,322 | |
| 09/13/2024 | 8.50 | 8.75 | 8.50 | 8.74 | 1,857 | |
| 09/12/2024 | 8.75 | 8.75 | 8.15 | 8.50 | 1,287 | |
| 09/11/2024 | 8.33 | 8.75 | 8.25 | 8.28 | 1,537 | |
| 09/10/2024 | 8.50 | 8.88 | 8.39 | 8.40 | 1,916 | |
| 09/09/2024 | 9.17 | 9.20 | 8.50 | 8.50 | 1,963 | |
| 09/06/2024 | 8.76 | 9.20 | 8.76 | 9.05 | 694.00 |
About Traws Pharma Stock history
Traws Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Traws is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Traws Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Traws Pharma stock prices may prove useful in developing a viable investing in Traws Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21 M | 15.7 M |
Traws Pharma Quarterly Net Working Capital |
|
Traws Pharma Stock Technical Analysis
Traws Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Traws Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Traws Pharma's price direction in advance. Along with the technical and fundamental analysis of Traws Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Traws to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.92) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | (2.66) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.